For Congenital Heart Defect Awareness Week, 50,000 Children Scanned Across India Using HD Steth


The week of February 7-14 marks Global Congenital Heart Defects (CHD) Awareness Week. In recognition of this week, HD Medical Inc, a Silicon Valley-based innovator, announced that it has screened more than 50,000 children for coronary heart disease using HD Steth â„¢ across India.

HD Steth is a smart stethoscope, developed by HD Medical Inc with three integrated ECG electrodes, which provides accurate and instant heart information.

These screenings have been carried out at various locations in India, and children diagnosed with coronary heart disease have received life-saving treatments and surgeries from Sri Sathya Sai Sanjeevani Hospitals in India.

Coronary heart disease affects large numbers of newborns and accounts for a high proportion of infant mortality worldwide. In fact, 1 in 100 babies are born with coronary heart disease worldwide, and almost 40,000 infants in the United States are born with coronary heart disease each year.

In India, pediatric cardiac care is still in its infancy, and there is not much data on the prevalence of coronary heart disease at birth or the proportional mortality from coronary heart disease. Resources are not only limited, but also sometimes misused.

According to the latest statistics, around 300,000 children are born with coronary heart disease each year and around 25% die before their first birthday. Lack of early detection and sophisticated pediatric care is the cause of more than 250 child deaths every day in India.

Global CHD Awareness Week is specifically designed to change this by attracting more support and investment for this cause. Innovations like HD Steth are a big step in this direction to diagnose the disease as early as possible.

HD Medical’s FDA-approved HD Steth solves this problem by providing a cost-effective, easy-to-use solution for non-specialists and primary health care professionals. HD Steth has been tested and validated in a clinical study involving 1,200 children, with a sensitivity of 91% and a specificity of 99% for the detection of heart murmurs caused by coronary heart disease compared to ultrasound echocardiograms as a reference to Sri Sathya Sai Sanjeevani Hospital in Raipur, Chhattisgarh State in central India.

Based on this study, HD Steth has been adopted into an extensive coronary heart disease screening program in their group hospitals and medical screening programs in several locations in India as follows:

Sai Sanjeevani Hospital in Palwal, Haryana: 12,974

Sai Sanjeevani Hospital in Kharghar, Maharashtra: 8,020

Sai Sanjeevani Hospital in Raipur, Chhattisgarh: 2,000

Sai Sanjeevani Initiative – Niraamaya Bastar: 1,000

Sai Sarla Memorial Hospital, Chickaballapur, Karnataka: 19,650

Sai Arogya Vahini Trust Mobile Medical Clinics, Calcutta, West Bengal: 8,450

Total number of children screened: 52,094

Total number of children screened and confirmed with CHD: 90+

Total number of children saved through heart surgeries: 36+

Sri Sathya Sai Sanjeevani Hospitals in Maharashtra, Chhattisgarh and Haryana are India’s largest providers of completely free pediatric cardiac procedures, performing nearly 14,000 surgeries and catheter procedures since 2012.

“The centers are committed to investing in child health initiatives for a healthier nation in the future by providing completely free quality health care,” said Mr. C Sreenivas, president of Sai Sanjeevani hospitals.

He added: “The HD Steth device from HD Medical is very useful in detecting children with coronary artery disease at an early stage so that rapid surgery may be possible to save their lives. HD Steth enables healthcare workers to screen children for coronary heart disease and refer them for follow-up care in our hospitals.

“We launched a screening program for over 100,000 children in Chickaballapur district in Karnataka state in October 2020 and so far we have tested nearly 20,000 children despite COVID-19,” said Dr Satish Babu, a distinguished endocrinologist trained at Cambridge University Hospital, King’s College Hospital and Cardiff University Hospital in the UK and currently practicing at Sri Sathya Sai Sarla Memorial Hospital, Muddenahalli near Bengaluru, Karnataka.

“We have also extended the HD Steth screening program to countries such as Fiji, Sri Lanka, Nigeria, Malaysia and the United States,” said Arvind Thiagarajan, Founder and CEO of HD Medical. “These screenings will target 500,000 children within a year, demonstrating HD Medical’s commitment to the cause of saving children through early detection of coronary heart disease with better technology.